Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anika Therapeutics (ANIK) Change in Taxes: 2011-2024

Historic Change in Taxes for Anika Therapeutics (ANIK) over the last 14 years, with Dec 2024 value amounting to $665,000.

  • Anika Therapeutics' Change in Taxes fell 101.69% to -$21,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$372,000, marking a year-over-year decrease of 137.58%. This contributed to the annual value of $665,000 for FY2024, which is 25.47% up from last year.
  • Per Anika Therapeutics' latest filing, its Change in Taxes stood at $665,000 for FY2024, which was up 25.47% from $530,000 recorded in FY2023.
  • Anika Therapeutics' 5-year Change in Taxes high stood at $1.4 million for FY2022, and its period low was -$2.1 million during FY2020.
  • Moreover, its 3-year median value for Change in Taxes was $665,000 (2024), whereas its average is $877,333.
  • As far as peak fluctuations go, Anika Therapeutics' Change in Taxes tumbled by 90.97% in 2020, and later skyrocketed by 209.61% in 2022.
  • Yearly analysis of 5 years shows Anika Therapeutics' Change in Taxes stood at -$2.1 million in 2020, then spiked by 36.73% to -$1.3 million in 2021, then surged by 209.61% to $1.4 million in 2022, then tumbled by 63.12% to $530,000 in 2023, then grew by 25.47% to $665,000 in 2024.